daratumumab and hyaluronidase-fihj (human recombinant)
daratumumab and hyaluronidase-fihj (human recombinant) is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Darzalex Faspro. Available dosage form: injection.
Drug details
- Generic Name
- daratumumab and hyaluronidase-fihj (human recombinant)
- Brand Names
- Darzalex Faspro
- Application Number
- BLA761145
- Sponsor
- Janssen Biotech, Inc.
- NDC Codes
- 3
- Dosage Forms
- INJECTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- DARATUMUMAB, HYALURONIDASE (HUMAN RECOMBINANT)